Summary

This is an ordinary civil lawsuit filed by Industria Avícola del Sur, S.A. against Lisa, S.A., seeking a declaration of extinctive prescription of dividends decreed in shareholder assemblies between 2001 and 2011. Lisa defended its rights by arguing that the dividends could not be considered prescribed due to embargo measures and ongoing shareholder disputes.

Decisions

Tenth First Instance Civil Court
February 12th, 2024
Issues

Whether Industria Avícola del Sur could invoke extinctive prescription over dividends decreed between 2001 and 2011.

Ruling

The Court ruled the claim inadmissible, holding that dividend rights are not subject to prescription under the Commercial Code and rejected the ordinary civil lawsuit.

Effect

The prescription lawsuit was dismissed, maintaining Lisa’s rights to dividends.

Order|Tenth Civil CourtFebruary 12th, 2024
Third Civil and Commercial Court of Appeals
June 30th, 2025
Issues

Appeal against the February 12, 2024 judgment dismissing the prescription claim.

Arguments

Lisa argued that the appeal should be denied and the lower court judgment confirmed, stressing that embargoes and judicial measures prevent the operation of prescription. A final appellate ruling is still pending.

Effect

The appeal filed by Industria Avícola del Sur remains pending resolution; Lisa filed its brief requesting confirmation of the lower court’s ruling.

Appeal|Lisa, S.A.June 30th, 2025

Conclusion

Lisa, S.A. prevailed in first instance. The Civil Court rejected the lawsuit for extinctive prescription, finding that dividends are shareholder rights that cannot be extinguished under the Commercial Code and that prescription did not apply. Industria Avícola del Sur appealed, but Lisa presented strong arguments in defense at the appellate stage, emphasizing that embargoes and pending proceedings interrupted or suspended any possible prescription. The outcome confirms Lisa’s shareholder rights and blocks Industria Avícola del Sur’s attempt to erase its dividend obligations through prescription.